El.En. S.p.A. (DE:EE5)
FRANKFURT:EE5
EE5 Stock Chart & Stats
€12.96
€0.04(0.36%)
At close: 4:00 PM EST
€12.96
€0.04(0.36%)
Day’s Range― - ―
52-Week Range€10.36 - €16.19
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€1.25B
Enterprise Value€1.14B
Total Cash (Recent Filing)€211.44M
Total Debt (Recent Filing)€38.07M
Price to Earnings (P/E)18.5
Beta0.82
Next Earnings
Sep 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.74
Shares Outstanding80,384,550
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-1.64
Price to Book (P/B)2.71
Price to Sales (P/S)1.89
P/FCF Ratio18.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€16.25Price Target Upside25.39% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.75
Revenue Forecast (FY)€627.72M
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet / Low LeverageA very low debt-to-equity (~0.09 in 2025) and steady equity growth give El.En. durable financial flexibility. This reduces refinancing risk, supports funding for R&D, capex or acquisitions, and provides a buffer through cyclical downturns that strengthens long-term resilience.
Diversified Product Mix And Recurring Service RevenueExposure to both medical and industrial end markets plus an installed-base driven services and consumables stream creates recurring revenue and lowers single-market dependence. This durable business model supports steadier lifecycle revenues and longer-term customer relationships.
Improved Free Cash Flow In 2024–2025The shift to solid positive free cash flow and FCF roughly tracking net income improves earnings quality and funds reinvestment, service network expansion, or shareholder returns without relying on new debt. Sustained FCF supports durable capital allocation choices.
Bears Say
2025 Gross-margin CompressionA notable gross-margin squeeze in 2025 suggests margin pressure from costs, pricing, or mix shifts. If persistent, lower gross margins reduce operating leverage and free cash flow, constraining reinvestment and weakening the firm's long-run profitability profile.
Volatile Revenue Trajectory With 2024 DeclineRevenue volatility, including a meaningful 2024 drop followed by a rebound, indicates demand cyclicality across medical and industrial markets. This makes long-term forecasting and capacity planning harder and can magnify margin and cash-flow swings across cycles.
Historic Operating Cash-flow VariabilityRecurring variability in operating cash flow versus earnings implies working-capital sensitivity and timing risks. Even with recent improvement, such swings can strain liquidity or force reliance on credit in weaker periods, limiting sustained investment or payout flexibility.
EE5 FAQ
What was El.En. S.p.A.’s price range in the past 12 months?
El.En. S.p.A. lowest stock price was €10.36 and its highest was €16.19 in the past 12 months.
What is El.En. S.p.A.’s market cap?
El.En. S.p.A.’s market cap is €1.25B.
When is El.En. S.p.A.’s upcoming earnings report date?
El.En. S.p.A.’s upcoming earnings report date is Sep 10, 2026 which is in 94 days.
How were El.En. S.p.A.’s earnings last quarter?
Currently, no data Available
Is El.En. S.p.A. overvalued?
According to Wall Street analysts El.En. S.p.A.’s price is currently Undervalued.
Does El.En. S.p.A. pay dividends?
El.En. S.p.A. does not currently pay dividends.
What is El.En. S.p.A.’s EPS estimate?
El.En. S.p.A.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does El.En. S.p.A. have?
El.En. S.p.A. has 80,384,550 shares outstanding.
What happened to El.En. S.p.A.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of El.En. S.p.A.?
Currently, no hedge funds are holding shares in DE:EE5
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
El.En. S.p.A.
EL.En. S.p.A. engages in the research and development, manufacture, distribution, and sale of laser systems in Europe and internationally. The company offers medical laser equipment for use in the fields of physiotherapy, orthopedics, traumatology, rheumatology, dermatology, sports and rehabilitative medicines, surgery, aesthetics, and art; and laser sources and systems for cutting, welding, marking, and engraving on countless materials. It also provides laser sources that include liquid, solid, semiconductor, and gas; and after-sales services, such as supplying of spare parts, as well as consulting and technical assistance services. The company was founded in 1981 and is headquartered in Calenzano, Italy.
EE5 Stock 12 Month Forecast
Average Price Target
€16.25
▲(25.39% Upside)
Technical Analysis
DiaSorin S.p.A.
―
Recordati Industria Chimica e Farmaceutica SPA
―
Garofalo Health Care S.P.A.
―
GPI SpA
―
I.M.D. International Medical Devices S.P.A.
―
Options Prices
Currently, No data available
---